 AUSTIN, Texas, May 13, 2021 GLOBE NEWSWIRE -- Molecular Templates, Inc. Nasdaq: MTEM, Molecular Templates, or MTEM, a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies ETBs, today reported financial results for the first quarter of 2021. 